MNKD
MannKind Corp
NASDAQ: MNKD · HEALTHCARE · BIOTECHNOLOGY
$2.75
-1.43% today
Updated 2026-04-29
Market cap
$849.19M
P/E ratio
137.50
P/S ratio
2.43x
EPS (TTM)
$0.02
Dividend yield
—
52W range
$2 – $7
Volume
6.3M
MannKind Corp (MNKD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-16.7%
Last 4 quarters
Revenue YoY growth
+45.8%
Most recent quarter
EPS YoY growth
-60.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-14.0%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $0.01 | -52.6% | $3.04 | $2.95 | -2.8% |
| 2025-11-05 | $0.07 | +250.0% | $5.48 | $5.70 | +4.0% |
| 2025-08-06 | $0.05 | +0.0% | $3.99 | $3.43 | -14.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.02 | $0.01 | -52.6% | $111.95M | +45.8% |
| 2025-09-30 | $0.02 | $0.07 | +250.0% | $82.13M | +17.2% |
| 2025-06-30 | $0.05 | $0.05 | +0.0% | $76.53M | +5.7% |
| 2025-03-31 | $0.06 | $0.04 | -33.3% | $78.35M | +18.2% |
| 2024-12-31 | $0.03 | $0.03 | -15.0% | $76.78M | +31.3% |
| 2024-09-30 | $0.03 | $0.05 | +66.7% | $70.08M | +36.7% |
| 2024-06-30 | $0.01 | $-0.01 | -200.0% | $72.39M | +48.9% |
| 2024-03-31 | $0.03 | $0.04 | +33.3% | $66.26M | +63.1% |
| 2023-12-31 | $0.01 | $0.00 | -57.0% | $58.47M | — |
| 2023-09-30 | $-0.02 | $0.01 | +150.0% | $51.25M | — |
| 2023-06-30 | $-0.04 | $-0.02 | +50.0% | $48.61M | — |
| 2023-03-31 | $-0.05 | $-0.04 | +20.0% | $40.63M | — |
Frequently asked questions
Has MannKind Corp beaten earnings estimates?
MannKind Corp has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -16.7% over the last 2 quarters.
How does MNKD stock react to earnings?
MNKD stock has moved an average of -4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is MannKind Corp's revenue growth rate?
MannKind Corp reported year-over-year revenue growth of +45.8% in its most recent quarter, with EPS growing -60.8% year-over-year.